Denali Therapeutics Inc. DNLI Weighted Average Exercise Price of Exercisable Options
Weighted Average Exercise Price of Exercisable Options at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s weighted average exercise price of exercisable options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s weighted average exercise price of exercisable options?
- Denali Therapeutics Inc. (DNLI) reported weighted average exercise price of exercisable options of $29.32 in Q1 2026.
- How has Denali Therapeutics Inc.'s weighted average exercise price of exercisable options changed year-over-year?
- Denali Therapeutics Inc.'s weighted average exercise price of exercisable options increased by 3.4% year-over-year, from $28.35 to $29.32.